GLP‑1 Drug Surge: How Employers Are Managing Rising Costs in 2025
GLP‑1 medications such as Ozempic®, Wegovy®, and Zepbound®—originally developed to treat Type 2 diabetes—have rapidly become some of the most prescribed drugs for weight management. While their clinical benefits are clear, their high costs are reshaping employer health plans in 2025 and creating pressure on pharmacy benefit budgets. Why GLP‑1s Are Driving Benefit Costs According […]